Intersect ENT (XENT) Misses Q1 EPS by 10c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Intersect ENT (XENT) PT Raised to $15 at SVB Leerink
May 12, 2020 12:29 PM EDTSVB Leerink analyst Richard Newitter raised the price target on Intersect ENT (NASDAQ: XENT) to $15.00 (from $13.00) while maintaining a Market Perform rating.
balance sheet overhang removed but COVID still adds uncertainty to turnaround... More